Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
As of 12/02 per OTC Markets.
https://www.otcmarkets.com/stock/TQLB/security
Outstanding Shares
63,471,826
12/02/2021
Restricted
46,450,000
12/02/2021
Unrestricted
17,021,826
12/02/2021
I totally believe we will see past 9+ bucks again. The new drink mixes are even better than the teas imo and taste better than most products out there. I've side by side personally compared them to crystal light, jolly rancher, and a bunch other dry mixes. I have even tried the bai ready drink mixes and Glucodown taste better than those. More and more diabetics are catching on and quite honestly these could even rebranded and spun as healthy choice for non diabetics out there. I was in Walmart tonight grabbing a few things for the kids and a new watermelon flavor of Monster Energy caught my eye, so I bought it. It is was pretty nasty and not even close to how delicious GlucoDown Watermelon is. Whatever they are doing in product development is solid and they should stick with it... $GLUC
What do you mean "you people"?..lol.
Didn't you buy a shix load here below a dime and ride it to 9 bucks? Lightning will strike here again!
Although you're still up over 1000%! Could be worse! (Just saying)
Agreed, the products are a hit and just a matter of time before large companies catch on to it. I think the majority of those selling are looking to claim tax losses. The L2 ask is still very thin. Once tax sellers clear out, those buying will likely see a 50-100% gain early next year. $GLUC.
Makes sense.. It would explain the consistency of the illiteracy!
Excessive paid pumping never works to garner momentum. It usually does more damage to the SP than good, as sophisticated players recognize it and avoid... Management (crooked or not) would be better off spending money on awareness via media ads and national or satellite radio spots.
Totally agree, many of the pumpers can't even conjunct a sentence properly. (Sweat labor pumpers obviously)
I do however see a good run potential here at these levels. I just really despise excessive paid pumping.
The company needs better exposure. Too many pumpers here and not enough national exposure..Here is a good way to get it on satellite radio.
http://undertheradarminute.com/episodes.htm
TQLB .045 low float..millions in po's lined up.
Supplement company geared towards muscle and health. Previous MSLP (muscle pharm) management with 63 mil OS and 17million unrestricted.
Just opened a 20k production facility and gaining attention/orders and placement at GNC. Possible early 2022 10 bagger imo. Chart looking to bounce out of bottom.
https://www.otcmarkets.com/stock/TQLB/news/story?e&id=1856235
Timing is everything! $TQLB
Hopefully cleared out everything below .049..we'll see what tomorrow brings?!... Either way..We're Gonna make a grip of cash on this one!
I'll try and paint 100k shares at .05 at close, but no telling how many GTSM has at .048
I'm taken her to .05 now before someone else does!
Indeed...love finding low floaters that are well positioned on revenue growth. Looks like it's previous MSLP management here! I made a killing on a low floater (GLUC)...Expecting the same with TQLB.
that was me..say goodbye to the .0481's
Very few fooled again...
Apparently these low level buy opportunities were created by your jinx. $GLUC
"Our relative silence on this and other subjects should not be misconstrued as a lack of commitment and ongoing focus to achieve this goal. We will make every effort to communicate where appropriate our progress regarding our listing efforts and acquisitions however we must maintain proper levels of discretion as needed."
Translation...We got nothing significant going on to report and our patent doesn't even work, but we need a few more brainless investors to convince of an Up-list so we can raise some cash for Christmas shopping...Merry Christmas! (Jmo)
Definitely a bunch of Turkeys here for Barry to carve up. Happy Thanksgiving!
Someone is gobbling up a few...$GLUC
Exactly what I have been saying..the vaccine is going to do more cardio-vascular damage to these people that may have never needed it in the first place. Over 95% of the population have a sufficient immune system or are low risk to defeat Covid via natural immunity...This vax is going to create bigger health issues and needed remedies than Covid infection ever would have. I hate to profit on a situation like this, but these people refuse to listen and are taking these vaccinations like good sheep are told. $CRXM
Nice...agree with your assessment.
The below was on page 11 of the April 10K (but not a peep since)
https://www.otcmarkets.com/filing/html?id=14889579&guid=ut8wkKyjFyTWdth
Angiogenic Research Initiative for COVID-19.
Early research has provided evidence of respiratory, neurological, and cardiac abnormalities in patients who have had severe COVID-19 immunological response requiring acute care (including protracted hospitalization and the need for mechanical ventilation). For patients who have survived and seek to return to normal life, several continuing residual adverse medical conditions appear to persist.
While the scientific literature remains uncertain, it has been suggested that mechanisms by which COVID-19 could lead to cardiovascular morbidity include direct myocardial injury as a result of inflammatory cascade or cytokine release, acute coronary syndrome from acute inflammation-triggered destabilization of atheroma, microvascular damage due to disseminated intravascular coagulation and thrombosis, direct entry of SARS-CoV-2 into myocardial cells via ACE2 receptors, and hypoxemia combined with metabolic demands of acute illness leading to myocardial injury akin to a myocardial infarction.
Based on these preliminary insights, Gene Biotherapeutics’ research is focused on the design of an observational clinical study to evaluate if COVID-19 may exacerbate microvascular damage and perfusion impairment in patients with pre-existing coronary artery disease and cardiac reversible perfusion defects (“RPD”) prior to COVID-19 infection. We are proposing to assess the damage using SPECT (Single-Photon Emission Computed Tomography) imaging to evaluate changes in RPD as a result of COVID-19 infection. Demonstration of worsening perfusion due to COVID-19 would be supportive of the potential to evaluate the therapeutic benefit of the Generx [Ad5FGF-4] product candidate angiogenic gene therapy in this patient population.
----------------------------------------------------------------
I wouldn't be surprised if there is not an abundant amount of long term cardiovascular damage to come from the jab and booster shots - more so than from actual Covid damage
"The Dangers of Booster Shots and COVID-19 ‘Vaccines’: Boosting Blood Clots and Leaky Vessels – Doctors for COVID Ethics" https://doctors4covidethics.org/boosting-blood-clots-and-leaky-vessels-the-dangers-of-covid-19-vaccines-and-booster-shots/
(download and read the entire article - might just save you from having to take gererx in the future)
The amount of damage that the vaccinations may be doing to the heart and vascular system may be a huge future market here as well for Generx. (Quite possibly even more so than Covid damage)
https://doctors4covidethics.org/leaky-blood-vessels-an-unknown-danger-of-covid-19-vaccination/
#thinkbeforethejab
According to the CTAP website, there are 60+ cell therapy trials for COVID underway. Is CRXM one of them? If not...Why not already! They are missing out on an explosive opportunity.
https://www.fda.gov/drugs/coronavirus-covid-19-drugs/coronavirus-treatment-acceleration-program-ctap
L2 is soooo thin. Just need decent volume and back above 5 in no time.
"Additionally, during this quarter, Glucose Health, Inc. will provide a progress report regarding its enterprise value enhancing, intellectual property initiative"
Lots of big words in that sentence..wonder what it is?
Until they layout their strategy for the future...the sp will continue lackluster performance. The past couple Q's have stated positive growth, but the sp remains dismal. A PR of growth plans and an up-list path is what is needed to garnish peak intest here... Until then, back to sleep cbmj.
Need some uplist directional news for this to get some real traction.
At .0001, tax sell off is no longer a concern...It's a gambler's opportunity.
Pointless to paint it back up. IF you are confident they will get current, then .0001 is irrelevant.
Company getting all the filings done would be a good start.
No one to blame but the company...had filings been completed on time, this would be a non-issue.
It doesn't take 8+ months to do that...another PR scam that will never happen...You're waiting for a train that ain't coming!
01/28/21
"ReelTime Engages Pinnacle Accountancy Group of Utah to" https://www.globenewswire.com/en/news-release/2021/01/28/2165863/0/en/ReelTime-Engages-Pinnacle-Accountancy-Group-of-Utah-to-Complete-NASDAQ-Listing-Requirement-of-Independently-Audited-Financials.html
...and probably using the proceeds to pay for their suite and booze at the Seahawks / Rams game tonight at Lumen Field.
PR release and 1.3 million sold with no sp increase.? It's the CEO and his buddies selling as usual. "Come on Man!"
20 million issued and sold since Feb... So much for increasing Shareholder value and reducing shares as PR'd by the CEO multiple times recently (Don't believe any PR here). At this rate, there will be 90 million outstanding by 1Q release of 2022 (if not more)
02/2021
Outstanding Shares
49,605,729
Unrestricted
28,103,315
10/2021
Outstanding Shares
69,577,631
Unrestricted
44,898,711
https://www.otcmarkets.com/stock/RLTR/security
Bad news for the World..Good news for GlucoDown...$GLUC
Good luck..the ceo, his brother and Mark S., just keep pumping and dumping it. They won't let the pps climb. Glad I sold for a profit here earlier. Buy elsewhere imo.